Wrongdoing by Pharmaceutical Manufacturers Results in $900,000 for NJ
New Jersey has received $900,000 as a result of its participation in separate global settlements resolving civil allegations against two pharmaceutical manufacturers and criminal charges against one of them.
Texas-based Healthpoint, Ltd. allegedly caused false Medicaid claims to be submitted for an unapproved medication known as Xenaderm. Meanwhile, California-based Victory Pharma is accused of paying unlawful inducements to physicians to prescribe its drugs.
Under the settlement, Healthpiont and its general partner DFB Pharmaceuticals has paid a total of $48 million to the federal government and 15 participating states, including New Jersey. Healthpoint’s settlement payout to New Jersey Medicaid of $607,704 was received last week.